A Novel Three-Gene Model Predicts Prognosis and Therapeutic Sensitivity in Esophageal Squamous Cell Carcinoma

Figure 3

Predictive value of the molecular model. (a) K-M survival curves showing that the OS and DFS had a striking contrast between the ESCC patients in low-, medium-, and high-risk groups. (b) Receiver operating characteristic (ROC) curve was used to evaluate the ability of the molecular model for OS or DFS compared with each biomarker alone or the pTMN-stage.

(a)

(b)